"Radiation Oncology and Brachytherapy"

During the past decade, Cancer Center of Putnam conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Center of Putnam" #1 collaborator was "NRG Oncology" with 2 trials as a collaborator and "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Center of Putnam" are "Breast Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Cancer Center of Putnam" in a lesser frequency.

Most popular intervention types in "Cancer Center of Putnam" are "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Concurrent boost" (1 trials), "Hypofractionated whole breast irradiation" (1 trials), "Sequential boost" (1 trials), "Standard fractionation whole breast irradiation" (1 trials) and "Whole-pelvic radiotherapy (WPRT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Center of Putnam" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Center of Putnam". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cancer Center of Putnam, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Center of Putnam, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".